Domov › Obézita › Arizona › Tucson
Klinické štúdie Obézita v meste Tucson, AZ
17 štúdií pre Obézita hľadá účastníkov v zariadeniach v meste Tucson a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Prebieha náborFáza 2
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Prebieha náborFáza 3
- University of Arizona, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Prebieha náborFáza 3
- Tucson Clinical Research Institute, Tucson
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Prebieha náborFáza 3
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Prebieha náborFáza 3
- Research Site, Tucson
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Prebieha náborFáza 3
- Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Prebieha náborFáza 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Prebieha náborFáza 3
- AURORA-1 Clinical Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Prebieha náborFáza 3
- AURORA-2 Clinical Site, Tucson
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Prebieha náborFáza 3
- Pima Heart and Vascular Clinical Research, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Prebieha náborFáza 3
- Arizona Clinical Trials, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Prebieha náborFáza 3
- Arizona Clinical Trials, Tucson
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov
- ACCOMPLISH-2 Research Site, Tucson
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Prebieha náborFáza 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Prebieha náborFáza 2
- Pima Heart, Tucson
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Prebieha náborFáza 3
- ACCOMPLISH-1 Research Site, Tucson
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
Prebieha náborFáza 1/2
- Adobe Clinical Research, Tucson
Štúdie Obézita v iných mestách
- Houston, TX43 štúdií
- Chicago, IL41 štúdií
- New York City, NY40 štúdií
- San Antonio, TX40 štúdií
- Washington, DC33 štúdií
- Orlando, FL31 štúdií
- Dallas, TX30 štúdií
- Boston, MA28 štúdií
- Las Vegas, NV27 štúdií
- Miami, FL27 štúdií
- Baltimore, MD25 štúdií
- Jacksonville, FL25 štúdií
Iné štúdie v Tucson
- Rakovina prsníka20 štúdií
- Nemalobunkový karcinóm pľúc17 štúdií
- Nadváha15 štúdií
- Metastatická rakovina14 štúdií
- Rakovina (všetky typy)12 štúdií
- Kardiovaskulárne ochorenia12 štúdií
- Kolorektálny karcinóm11 štúdií
- Rakovina prostaty11 štúdií
- Steatotické ochorenie pečene10 štúdií
- Srdcové zlyhanie10 štúdií
- Vysoký krvný tlak10 štúdií
- Diabetes mellitus 2. typu10 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.